Eaton Vance Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,745
| Closed | -$120K | – | 2041 |
|
|
2021
Q4 | $120K | Buy |
2,745
+782
| +40% | +$34.2K | ﹤0.01% | 1762 |
|
|
2021
Q3 | $31K | Sell |
1,963
-161
| -8% | -$2.54K | ﹤0.01% | 1587 |
|
|
2021
Q2 | $133K | Sell |
2,124
-446,351
| -100% | -$27.9M | ﹤0.01% | 1773 |
|
|
2021
Q1 | $41.7M | Sell |
448,475
-8,293
| -2% | -$771K | 0.06% | 297 |
|
|
2020
Q4 | $40.9M | Buy |
456,768
+77,233
| +20% | +$6.92M | 0.06% | 278 |
|
|
2020
Q3 | $39.2M | Buy |
379,535
+5,451
| +1% | +$563K | 0.07% | 246 |
|
|
2020
Q2 | $29.6M | Sell |
374,084
-25,100
| -6% | -$1.98M | 0.06% | 272 |
|
|
2020
Q1 | $23.1M | Sell |
399,184
-81,500
| -17% | -$4.72M | 0.06% | 276 |
|
|
2019
Q4 | $25.9M | Buy |
480,684
+286,263
| +147% | +$15.4M | 0.05% | 287 |
|
|
2019
Q3 | $10.2M | Buy |
+194,421
| New | +$10.2M | 0.02% | 437 |
|